Search

Elotuzumab

Elotuzumab is a humanized IgG1 (Immunoglobulin G) monoclonal antibody indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to … Elotuzumab is marketed under the brand Empliciti™ by Bristol-Myers Squibb.

Barnidipine

According to a dose-ranging, multicentre, placebo-controlled, double-blind study in patients with mild to moderate hypertension, the antihypertensive response from barnidipine treatment was maintained … In two European multicentre randomized, double-blind trials, barnidipine was shown to possess equivalent antihypertensive efficacy to amlodipine and nitrendipine, but produced fewer class-specific side-effects

Noscapine

Ergometrine

An ergot alkaloid with uterine and vascular smooth muscle contractile properties.

Methsuximide

It is sold by Pfizer under the name Petinutin.

Sodium phosphate, dibasic, unspecified form

Mevastatin

Mevastatin or compactin is a cholesterol-lowering agent isolated from <i>Penicillium citinium</i>. … During a search for antibiotic compounds produced by fungi in 1971, Akira Endo at Sankyo Co. (Japan) discovered a class of compounds that appeared to lower plasma cholesterol levels.

Fibrinogen human

It works by replacing a specific protein in the blood, fibrinogen (factor I), that helps with blood clotting.

Dipyrithione

Dipyrithione, a bactericidal and fungicidal pyrithione derivate, was formulated as Crimanex anti-dandruff shampoo, but is no longer available. … [A32825] It may be combined with other ingredients, such as triclosan to serve as antifungal and antibacterial skin treatments.

Macimorelin

In addition, individuals with may be susceptible to cardiovascular complications from altered structures and function [A31484]. … Macimorelin, developed by Aeterna Zentaris, was approved by the FDA in December 2017 under the market name Macrilen for oral solution.